Evolus targets $450M-$500M revenue and 13%-15% adjusted EBITDA margin in 2028 while raising 2026 revenue outlook to $330M-$337M — See source for full details.
$EOLS
Price history, market instrument context, member research, and related headlines in one place.
EOLS key statistics
NasdaqGMUSD
52-week range
$3.8668%$9.31
Latest session $7.23–$7.71Evolus, Inc. (EOLS) is a stock instrument quoted on NasdaqGM in USD. The most recently published price is $7.57, up $0.35 (4.85%) from the previous close of $7.22. It has traded between $7.23 and $7.71 in the latest session. Over the past year it has ranged from $3.86 to $9.31, leaving it in the upper half of its 52-week range (68%). Reported volume for the session was 901.5K. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Evolus GAAP EPS of -$0.12 beats by $0.01, revenue of $84.1M beats by $2.56M — See source for full details.
Loading $EOLS research…